PROLOG
Dead / Abandoned — Abandoned — no statement of use filed (as of 23 Mar 2026)
What this means for you
This application is over — abandoned 23 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97900474
- Mark type
- Stylized text
- Filed
- 21 Apr 2023
- Published for opposition
- 25 Jun 2024
- Abandoned
- 23 Mar 2026
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, immunological diseases and disorders, metabolic diseases and disorders, endocrine diseases and disorders, kidney diseases and disorders, dermatological diseases and disorders, reproductive diseases and disorders, urological diseases and disorders, allergies, bone diseases and disorders, diseases and disorders of the musculo-skeletal and genitourinary systems, and viruses and infectious diseases
Owner
- PROLOGUE MEDICINES, INC., CAMBRIDGE, MA, US
- PROLOGUE MEDICINES, INC., CAMBRIDGE, MA, US
- Flagship Labs 89, Inc., Cambridge, MA, US
Prosecution history
- 23 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 23 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 16 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Aug 2025 — SOU EXTENSION 2 GRANTED
- 15 Aug 2025 — SOU EXTENSION 2 FILED
- 15 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 1 GRANTED
- 13 Feb 2025 — SOU EXTENSION 1 FILED
- 13 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2024 — PUBLISHED FOR OPPOSITION
- 05 Jun 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER